IP Library Granted Patent US 10,292,635
Granted Patent B2
US 10,292,635 · App. 14/771,965 · Granted May 21, 2019

System and method for assessing impulse control disorder

Inventors: Robert Irwin Griffiths (Melbourne, AU); Malcolm Kenneth Home (Melbourne, AU); Andrew H. Evans (Melbourne, AU)
Assignee: Global Kinetics Pty Ltd
A61B5/16A61B5/4076G06F19/00G06F19/3456G09B19/00G16H50/30A61B5/4082A61B5/4833A61B5/6887
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,292,635
App. No.
14/771,965
Granted
May 21, 2019
Kind
B2
Abstract

A method of assessing the likelihood that an individual has impulse control disorder. The individual is provided with an actuator, and instructed to actuate the actuator as an acknowledgement of when the individual has completed a reward task. Actuation of the actuator is monitored and recorded. An automated diagnosis of ICD is produced and output, wherein a greater degree of actuation of the actuator by the individual is taken to indicate a greater likelihood that the individual has impulse control disorder.

Claims (10)

1. A method of using an actuator to assess likelihood that an individual has impulse control disorder, the method comprising:

providing the individual with the actuator, and instructing the individual to actuate the actuator as an acknowledgement of when the individual has taken medication;

monitoring and recording the actuation of the actuator, wherein the actuator is located on a device that reminds the individual to take medication, wherein the device is configured to remind the individual to take medication when required, and wherein the actuator deactivates the reminder to indicate that the medication has been taken;

producing, by a processor, an automated diagnosis of the likelihood of impulse control disorder, wherein a greater degree of actuation of the actuator by the individual is taken to indicate a greater likelihood that the individual has impulse control disorder; and

outputting the automated diagnosis of the likelihood that the individual has impulse control disorder.

2. The method of claim 1 wherein performance of the taking of the medication by the individual is not monitored by actuation of the actuator.

3. The method of claim 1 wherein the actuator is at least one of a button, dial, lever, questionnaire tick-box, and a sensor or input device responsive to a motor response of the individual.

4. The method of claim 1 wherein the device is body-worn.

5. The method of claim 1 wherein the device is located separate from the individual.

6. The method of claim 1 further comprising generating an output that the individual is at-risk of impulse control disorder when the individual actuates the actuator by an amount which is moderately more than expected, and generating an output that the individual has impulse control disorder when the individual actuates the actuator by an amount which is significantly more than expected.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2018
From: GLOBAL KINETICS CORPORATION LIMITED
To: GLOBAL KINETICS PTY LTD
Reel/Frame 047763/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2018
From: GLOBAL KINETICS CORPORATION LIMITED
To: GLOBAL KINETICS PTY. LTD.
Reel/Frame 047163/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2018
From: GRIFFITHS, ROBERT IRWIN; HORNE, MALCOLM KENNETH; EVANS, ANDREW H.
To: GLOBAL KINETICS CORPORATION LIMITED
Reel/Frame 044868/0665 →
Priority Claims (2)
AU 2013900705 · Mar 1, 2013 · national
AU 2013903014 · Aug 9, 2013 · national
Continuity (1)
Related Publication 20160022192A1 · Jan 28, 2016